Accuray Inc (ARAY)
2.08
+0.06
(+2.98%)
USD |
NASDAQ |
Nov 07, 16:00
2.10
+0.02
(+0.96%)
After-Hours: 20:00
Accuray Revenue (TTM): 446.55M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 446.55M |
| March 31, 2024 | 430.55M |
| December 31, 2023 | 447.48M |
| September 30, 2023 | 455.00M |
| June 30, 2023 | 447.60M |
| March 31, 2023 | 439.34M |
| December 31, 2022 | 417.44M |
| September 30, 2022 | 418.96M |
| June 30, 2022 | 429.91M |
| March 31, 2022 | 430.82M |
| December 31, 2021 | 437.22M |
| September 30, 2021 | 418.40M |
| June 30, 2021 | 396.29M |
| March 31, 2021 | 380.33M |
| December 31, 2020 | 377.32M |
| September 30, 2020 | 378.68M |
| June 30, 2020 | 382.93M |
| March 31, 2020 | 405.37M |
| December 31, 2019 | 409.04M |
| September 30, 2019 | 412.53M |
| June 30, 2019 | 418.78M |
| March 31, 2019 | 415.15M |
| December 31, 2018 | 411.76M |
| September 30, 2018 | 409.78M |
| June 30, 2018 | 404.90M |
| Date | Value |
|---|---|
| March 31, 2018 | 403.20M |
| December 31, 2017 | 400.68M |
| September 30, 2017 | 387.86M |
| June 30, 2017 | 383.41M |
| March 31, 2017 | 366.29M |
| December 31, 2016 | 374.26M |
| September 30, 2016 | 395.68M |
| June 30, 2016 | 398.80M |
| March 31, 2016 | 405.58M |
| December 31, 2015 | 397.81M |
| September 30, 2015 | 387.05M |
| June 30, 2015 | 379.80M |
| March 31, 2015 | 380.05M |
| December 31, 2014 | 379.68M |
| September 30, 2014 | 375.16M |
| June 30, 2014 | 369.42M |
| March 31, 2014 | 352.32M |
| December 31, 2013 | 325.72M |
| September 30, 2013 | 309.87M |
| June 30, 2013 | 315.97M |
| March 31, 2013 | 331.61M |
| December 31, 2012 | 362.88M |
| September 30, 2012 | 391.52M |
| June 30, 2012 | 409.22M |
| March 31, 2012 | 383.91M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
377.32M
Minimum
Dec 2020
455.00M
Maximum
Sep 2023
418.38M
Average
418.96M
Median
Sep 2022
Revenue (TTM) Benchmarks
| Boston Scientific Corp | 15.91B |
| Baxter International Inc | 15.00B |
| AngioDynamics Inc | 292.73M |
| Masimo Corp | 2.043B |
| Perspective Therapeutics Inc | -- |